Exp Clin Endocrinol Diabetes 2000; Vol. 108(2): 120-127
DOI: 10.1055/s-2000-5805
Articles

© Johann Ambrosius Barth

Characterization of the neuroprotective effects of estrogens onhydrogen peroxide-induced cell death in hippocampal HT22 cells:time and dose-dependency

H. Vedder, M. Teepker, S. Fischer, J.-C. Krieg
  • Department of Psychiatry and Psychotherapy, Philipps-University, Marburg, Germany
Further Information

Publication History

Publication Date:
31 December 2000 (online)

Summary:

Time and dose-dependency of the effects of estrogens (17-β estradiol, estrone) and non-estrogenic steroids (progesterone, dexamethasone and methylprednisolone) on the toxicity of hydrogen peroxide were examined in mouse hippocampal HT22 cells.

Hydrogen peroxide, an important intermediate of various disease-relevant oxidative stressors, induced cell death in HT22 cells in extracellular concentrations between 0.5 and 1.5 mM in a dose-dependent manner (EC50 = 0.95 mM). Regarding the underlying mechanisms of toxicity, incubation with hydrogen peroxide did not induce lipid peroxidation in living HT22 cells under these conditions. After preincubation with estrogens and non-estrogenic steroids for 22 hours, estrogen compounds protected the cells against hydrogen peroxide toxicity. Estrogens showed a maximal protective effect at 60-70% of hydrogen peroxide toxicity which diminished at higher and lower concentrations of the toxic challenge. Dose-dependency studies of estrogens revealed that concentrations of 1 μM already exerted a significant cytoprotective effect. Co- and postincubation with 17-β estradiol and estrone also resulted in significant cell protection even if the estrogens were added 30 min after the initiation of the challenge with hydrogen peroxide.

In contrast, preincubation with other steroids like progesterone, a physiological gonadal steroid, dexamethasone, a synthetic glucocorticoid and methylprednisolone, a glucocorticoid with radical scavenging properties, did not protect the cells against hydrogen peroxide toxicity but resulted in a dose-related decrease of HT22 cell survival in the course of the toxic challenge.

References

  • 1 Angermeyer M C, Kühn L. Gender differences in age at onset of schizophrenia.  Eur Arch Psychiatr Neurol Sci. 237 351-364 1988; 
  • 2 Beato M, Arnemann J, Chalepakis G. Gene regulation by steroid hormones.  J Steroid Biochem. 27 9-14 1987; 
  • 3 Behl C, Davis J B, Lesley R, Schubert D. Hydrogen peroxide mediates amyloid-β-protein toxicity.  Cell. 77 817-827 1994; 
  • 4 Behl C, Lezoualc'h F, Trapp T, Widmann M, Skutella T, Holsboer F. Glucocorticoids enhance oxidative stress-induced cell death in hippocampal neurons in vitro.  Endocrinol. 138 101-106 1997; 
  • 5 Behl C, Widmann M, Trapp T, Holsboer F. 17-β estradiol protects neurons from oxidative stress-induced cell death in vitro.  Biochem Biophys Res Comm. 216 473-482 1995; 
  • 6 Birge S J. The role of estrogen in the treatment of Alzheimer's disease.  Neurol. 48 S36-S41 1997; 
  • 7 Bracken M B, Shepard M J, Collins W F, Holford T R, Young W, Baskin D S, Eisenberg H M, Flamm E, Leo-Summers L, Maroon J, Sonntag V KH, Wagner F C, Wilberger J E, Winn H R. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury.  N Engl J Med. 322 1405-1411 1990; 
  • 8 Bukusoglu C, Krieger N R. Estrogen-specific target site identified by progesterone-11α-hemisuccinate-(2-[125J]-iodohistamine) in mouse brain membranes.  J Steroid Biochem Mol Biol. 58 89-94 1996; 
  • 9 Davis J B, Maher P. Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line.  Brain Res. 652 169-173 1994; 
  • 10 Farber J, Kyle M, Coleman J. Biology of disease - Mechanisms of cell injury by activated oxygen species.  Lab Invest. 62 670-679 1990; 
  • 11 Haaf H, Li S A, Li J J. Covalent binding of estrogen metabolites to hamster liver microsomal proteins: inhibition by ascorbic acid and catechol-O-methyl transferase.  Carcinogen. 8 209-215 1987; 
  • 12 Häfner H, Behrens S, de Vry J, Gattaz W F, Löffler W, Maurer K, Riecher-Rössler A. Warum erkranken Frauen später an Schizophrenie? Erhöhung der Vulnerabilitätsschwelle durch Östrogene.  Nervenheilkunde. 10 154-163 1991; 
  • 13 Hall E D. Neuroprotective actions of glucocorticoid and nonglucocorticoid steroids in acute neuronal injury.  Cell and Mol Neurobiol. 13 415-432 1993; 
  • 14 Hall E D. The neuroprotective pharmacology of methylprednisolone.  J Neurosurg. 76 13-22 1992; 
  • 15 Halliwell B, Gutteridge J MC. Free radicals in biology and medicine. p. 188-266 Oxford University Press 1989
  • 16 Hansen M B, Nielsen S E, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell killing.  J Immunol Meth. 119 203-210 1989; 
  • 17 Hobkirk R. Sulfation by guinea pig chorion and uterus: differential action towards estrone and estradiol.  J Steroid Biochem Mol Biol. 59 479-484 1996; 
  • 18 Hoyt K R, Gallagher A J, Hastings T G, Reynolds I J. Characterization of hydrogen peroxide toxicity in cultured rat forebrain neurons.  Neurochem Res. 22 333-340 1997; 
  • 19 Kawas C, Resnick S, Morrison A, Brookmeyer R, Corrada M, Zonderman A, Bacal C, Lingle D D, Metter E A. Prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal study of aging.  Neurol. 48 1517-1521 1997; 
  • 20 Komuro E, Takahashi M, Morita T, Tsuchiya J, Arakawa J, Yamamoto Y, Niki E. Inhibition of peroxidations of lipids and membranes bei estrogens.  J Phys Org Chem. 3 309-315 1990; 
  • 21 Lacort M, Leal A M, Liza M, Martin C, Martinez R, Ruiz-Larrea M B. Protective effect of estrogens and catecholestrogens against peroxidative membrane damage in vitro.  Lipids. 30 141-146 1995; 
  • 22 Lowry O H, Rosebrough N J, Farr A L, Randall R J. Protein measure-ment with the Folin phenol reagent.  J Biol Chem. 193 265-275 1951; 
  • 23 Mooradian A D. Antioxidant properties of steroids.  J Steroid Biochem Mol Biol. 45 509-511 1993; 
  • 24 Moosmann B, Uhr M, Behl C. Neuroprotective potential of aromatic alcohols against oxidative cell death.  FEBS Lett. 413 467-472 1997; 
  • 25 Morimoto B H, Koshland D E. Induction and expression of long- and short-term neurosecretory potentiation in a neural cell line.  Neuron. 5 875-880 1990; 
  • 26 Neugebauer E, Dietrich A, Bouillon B. Steroids in trauma patients - right or wrong? A qualitative metaanalysis of clinical studies.  Theoret Surg. 5 44-53 1990; 
  • 27 Nohl H. Generation of superoxide radicals as byproducts of cellular respiration.  Ann Biol Clin. 52 199-204 1994; 
  • 28 Nohl H. Involvement of free radicals in ageing: a consequence or cause of senescence.  Brit Med Bull. 49 653-667 1993; 
  • 29 Nohl H, Jordan W. The metabolic fate of mitochondrial hydrogen peroxide.  Eur J Biochem. 111 203-210 1980; 
  • 30 Ohkawa H, Oshishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction.  Anal Biochem. 95 351-358 1979; 
  • 31 Okuda S, Nishiyama N, Saito H, Katsuki H. Hydrogen peroxide-mediated neuronal cell death induced by endogenous neurotoxin, 3-hydroxykynurenine.  Proc Natl Acad Sci USA. 93 1253-1258 1996; 
  • 32 Olanow C W. A radical hypothesis for neurodegeneration.  TINS. 16 439-444 1993; 
  • 33 Riederer P, Sofic E, Rausch W D, Schmidt B, Reynolds G P, Jellinger K, Youdim M BH. Transition metals, Ferritin, Glutathione, and Ascorbic acid in Parkinsonian brains.  J Neurochem. 52 515-520 1989; 
  • 34 Rifici V A, Khachadurian A K. The inhibition of low-density lipoprotein-oxidation by 17-β estradiol.  Metabolism. 41 1110-1114 1992; 
  • 35 Roof R L, Duvdevani R, Braswell L, Stein D G. Progesterone facilitates cognitive recovery and reduces secondary neuronal loss caused by cortical contusion injury in male rats.  Exp Neurol. 129 64-69 1994; 
  • 36 Ruiz-Larrea B, Leal A, Lacort M, de Groot H. Antioxidant effects of estradiol and 2-hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsomes.  Steroids. 59 383-388 1994; 
  • 37 Sapolsky R M, Pulsinelli W A. Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications.  Sciencee. 229 1397-1400 1985; 
  • 38 Schmidt R, Fazekas F, Reinhart B, Kapeller P, Fazekas G, Offenbacher H, Eber B, Schumacher M, Freidl W. Estrogen replacement therapy in older women: a neuropsychological and brain MRI study.  J Am Geriatr Soc. 44 1307-1313 1996; 
  • 39 Sparre L S, Brundin J, Carlstrom A, von Schoultz B, Carlstrom K. Serum levels of estrogens and of five `steroid-sensitive' proteins in early normal pregnancy.  Acta Endocrinol Copenh. 118 239-244 1988; 
  • 40 Wilbur K M, Bernheim F, Shapiro O W. Determination of Lipid peroxidation.  Arch Biochem. 24 305-310 1949; 

Dr. H. Vedder

Department of Psychiatry and Psychotherapy

Philipps-University of Marburg

Rudolf-Bultmann-Str. 8

D-35033 Marburg, Germany

Phone: +49-64 21-286-6429

Fax: +49-64 21-286-8939

Email: vedder@mailer.uni-marburg.de